Abstract
The effects of topical application of arachidonic acid (AA) or phorbol ester, tetradecanoylphorbol 13-acetate (TPA), on edema response, vascular permeability, MPO, NAG, and generation of eicosanoids were studied in two murine models of cutaneous inflammation. AA produced a short-lived edema response with a rapid onset that was associated with marked increases in levels of prostaglandins (PGE2, 6-keto-PGF1α, PGF2α), thromboxane B2 (TxB2) and leukotriene B4 (LTB4), with smaller increases in levels of LTC4. TPA produced a longer-lasting edema that was associated with marked influx of neutrophils and predominant formation of LTB4 along with significant changes in levels of TxB2. Circulating T lymphocytes have no apparent role in the acute inflammatory responses induced by either agent. Arachidonic acid-induced vascular permeability preceded the edema response and neutrophil influx, whereas TPA-induced vascular permeability paralleled the edema response and influx of neutrophils. Mast cells appear to be important in the complete expression of inflammatory response, i.e., edema, cellular influx, and vascular permeability induced by either AA or TPA, as these responses were blunted in mast cell-deficient mice. Inhibitors of CO or 5-LO attenuated inflammatory responses in both models. The LTB4 receptor antagonist, SC-41930, inhibited the inflammatory response to TPA but had little effect on that initiated by AA. This suggests that LTB4 is an important mediator in the phorbol ester-induced inflammatory response, whereas peptidoleukotrienes and prostaglandins regulate vascular permeability responses in the arachidonate model.
Similar content being viewed by others
References
Wershill, B. K., Y. A. Mekori, T. Murakami, andS. J. Galli. 1987.125I-Fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells.J. Immunol. 139:2605–2614.
Yano, H., B. K. Wershill, N. Arizono, andS. J. Galli. 1989. Substance-P induced augmentation of cutaneous vascular permeability in mice is mast cell dependent.J. Clin. Invest. 84:1276–1296.
Ramos, B. F., Y. Zhang, R. Qureshi, andB. A. Jakschik. 1991. Mast cells are critical for production of leukotrienes responsible for neutrophil recruitment in immune complex-induced peritonitis in mice.J. Immunol. 147:1636–1641.
Ramos, B. F., R. Qureshi, K. M. Olsen, andB. A. Jakschik. 1990. The importance of mast cells for the neutrophil influx in immune complex-induced peritonitis in mice.J. Immunol. 145:1866–1873.
Ramos, B. F., Y. Zhang, V. Angkachatchai, andB. A. Jakschik. 1992. Mast cells regulate vascular permeability changes in Arthus reaction.J. Pharmacol. Exp. Ther. 262:559–565.
Zhang, Y., B. F. Ramos, andB. A. Jakschik. 1991. Augmentation of reverse Arthus reaction by mast cells in mice.J. Clin. Invest. 88:841–846.
Zhang, Y., B. F. Ramos, andB. A. Jakschik. 1992. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis.Science 258:1957–1959.
Chang, J., R. P. Carlson, L. O'Neill-Davis, B. Lamb, R. N. Sharma, andA. J. Lewis. 1986. Correlation between mouse skin inflammation induced by arachidonic acid and eicosanoid synthesis.Inflammation 10:205–214.
Opas, E. E., R. J. Bonney, andJ. L. Humes. 1985. Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid.J. Invest. Dermatol. 84:253–256.
Davies, P., P. J. Bailey, R. Goldberg, andW. A. Ford-Hutchinson. 1984. The role of arachidonic acid oxygenation products in pain and inflammation.Annu. Rev. Immunol. 2:337–357.
Williams, T. J. 1979. Prostaglandin E2, prostaglandin I2 and the vascular changes in inflammation.Br. J. Pharmacol. 65:517–524.
Williams, T. J. 1983. Interactions between prostaglandins leukotrienes and other mediators of inflammation.Br. Med. Bull. 30:239–242.
Humes, J. L., E. E. Opas, andR. J. Bonney. 1989. Arachidonic acid metabolites in mouse ear edema.In Advances in Inflammation Research, Vol. 11. I. Otterness, A. L. Lewis, and R. Capetola, editors. Raven Press, New York. 57–65.
Carlson, R. P., L. O'Neill-Davis, J. Chang, andA. J. Lewis. 1985. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.Agents Actions 17:197–204.
Young, J. M., J. A. Spires, C. D. Bedford, B. Wagner, S. J. Ballron, andL. M. De Young. 1984. The mouse ear inflammatory response to topical arachidonic acid.J. Invest. Dermatol. 82:367–371.
Carter, G. W., P. R. Young, D. H. Albert, J. Bouska, R. Dyer, R. L. Bell, J. B. Summers, andD. W. Brooks. 1991. 5-Lipoxygense inhibitory activity of zileuton.J. Pharmacol. Exp. Ther. 256:929–937.
Ashendel, C. L., andR. K. Boutwell. 1979. Prostaglandin E and F levels in mouse dermis are increased by tumor promoting phorbol esters.Biochem. Biophys. Res. Commun. 90:623–627.
Marks, F., G. Fusterberger, andE. Kowantzki. 1981. Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A 23187 and by tumor promotor 12-O-tetradecanoylphorbol-13-acetate.Cancer Res. 41:696–702.
Fustenberger, G., andF. Marks. 1982. Early prostaglandin E synthesis is an obligatory event in induction of cell proliferation in mouse epidermis in vivo by phorbol ester TPA.Biochem. Biophys. Res. Commun. 92:749–756.
Young, J. M., B. M. Wagner, andD. A. Spires. 1983. Tachyphylaxis in 12-O-tetradecanoylphorbol-13-acetate and arachidonic acid-induced ear edema.J. Invest. Dermatol. 80:48–52.
Ackerman, N. R., E. C. Arner, H. Galbraith, R. R. Harris, B. D. Jaffe, andW. M. Macki. 1986. Anti-inflammatory consequences of 5-lipoxygenase inhibition.Adv. Prostaglandin, Thromboxane, Leukotriene Res. 16:47–56.
Gillard, J., A. W. Ford-Hutchinson, C. Chan, S. Charleson, D. Denis, R. Foster, R. Frtlin, S. Leger, C. S. McFarlane, H. Morton, H. Piechuta, D. Riendeau, C. A. Rouzer, J. Rokash, R. Young, D. E. McIntyre, L. Peterson, G. Bach, E. Eiermann, S. Hopple, J. Humes, L. Hupe, S. Luell, J. Metzger, R. Mauer, D. K. Miller, E. Opas, andS. Pacholok. 1989. L-663,356 (MK-886) {3-[l-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid}, a novel, orally active leukotriene biosynthesis inhibitor.Can. J. Physiol. Pharmacol. 67:456–464.
Fretand, D., S. Widomski, B. Tsai, J. Zemaitis, S. Levin, S. Djuric, R. Shone, andT. Gaginella. 1990. Effect of the LTB4 receptor antagonist, SC-41930 on colonic inflammation in rat, guinea pig and rabbit.J. Pharmacol. Exp. Ther. 255:572–576.
Fretland, D., D. Widomski, J. Zemaitis, S. Djuric, andR. Shone. 1990. Effect of a leukotriene receptor antagonist on LTB4 -induced neutrophil chemotaxis in cavine dermis.Inflammation 13:601–605.
Villani-Price, D., D. Yang, R. Walsh, D. Fretland, R. Keith, G. Kokan, T. Gaginella, andB. S. Tsai. 1992. Multiple actions of the leukotriene B4 receptor antagonist, SC-41930.J. Pharmacol. Exp. Ther. 260:187–191.
Fleisch, J. H., L. E. Rinkema, K. D. Haisch, T. Swanson-Bean, T. Goodson, P. P. K. Ho, andW. S. Marshall. 1985. LY-171883 {l-[2-hydroxy-3-propyl-4-(1H-tetrazol-5-yl)butoxy-phenylethanone]}, an orally active leukotriene D4 antagonist.J. Pharmacol. Exp. Ther. 233:148–157.
Bradley, P. B., D. A. Pribat, R. O. Christensen, andG. Rothstein. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker.J. Invest. Dermatol. 78:206–209.
Schultz, J., andK. Kaminker. 1962, Myeloperoxidase of the leucocyte of normal human blood I. Content and localization.Arch. Biochem. Biophys. 525:37–44.
Bailey, P., J. A. Sturm, andB. Lopez-Ramos. 1982. A biochemical study of the cotton pellet granuloma in the rat.Biochem. Pharmacol. 31:1213–1218.
Griswold, D. E., S. Hoffstein, P. J. Marshall, D. F. Webb, L. Hillegass, P. E. Bender, andN. Hanna. 1983. Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.Inflammation 13:727–739.
Otterness, I. G., andM. L. Blivan. 1985. Laboratory models for testing non-steroidal antiinflammatory drugs.In Nonsteroidal Antiinflammatory Drugs. J. G. Lobardino, editor. John Wiley, New York. 116–252.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rao, T.S., Currie, J.L., Shaffer, A.F. et al. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17, 723–741 (1993). https://doi.org/10.1007/BF00920477
Issue Date:
DOI: https://doi.org/10.1007/BF00920477